Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125302451 | 12530245 | 1 | I | 2016 | 20160621 | 20160706 | 20160706 | PER | US-PFIZER INC-2016311964 | PFIZER | 60.00 | YR | Y | 0.00000 | 20160706 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125302451 | 12530245 | 1 | PS | SERTRALINE HCL | SERTRALINE HYDROCHLORIDE | 1 | Oral | 75 MG, DAILY (50 MG ORAL TABLET, ONE HALF DAILY ) | U | 19839 | 75 | MG | FILM-COATED TABLET | ||||||
| 125302451 | 12530245 | 2 | SS | SERTRALINE HCL | SERTRALINE HYDROCHLORIDE | 1 | Oral | 50 MG, DAILY (50 MG ORAL TABLET, 1 DAILY) | U | 19839 | 50 | MG | FILM-COATED TABLET |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125302451 | 12530245 | 1 | Adjustment disorder |
| 125302451 | 12530245 | 2 | Depressed mood |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125302451 | 12530245 | Anxiety |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125302451 | 12530245 | 1 | 20160201 | 20160206 | 0 | |
| 125302451 | 12530245 | 2 | 20160207 | 0 |